BECTON DICKINSON & CO (BDX)
Healthcare · Surgical & Medical Instruments & Apparatus
BECTON DICKINSON & CO (BDX) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| GREENHAVEN ASSOCIATES INC | 5,904,730 | .06B | 2.17% |
| ProShare Advisors LLC | 1,119,563 | $200.40M | 0.41% |
| MACKENZIE FINANCIAL CORP | 1,112,868 | 99.20M | 0.41% |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 1,112,534 | 99.14M | 0.41% |
| COOKE & BIELER LP | 854,452 | 52.95M | 0.31% |
| Sumitomo Mitsui Trust Group, Inc. | 679,261 | 21.59M | 0.25% |
| DAVENPORT & Co LLC | 607,325 | 09.23M | 0.22% |
| EVERETT HARRIS & CO /CA/ | 557,224 | $99.74M | 0.20% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-10-26 | Feld Michael | EVP, Chief Revenue Officer | Sale | 5.1K |
| 2026-09-28 | Feld Michael | EVP, Chief Revenue Officer | Sale | 4.0K |
| 2026-08-26 | Feld Michael | EVP, Chief Revenue Officer | Sale | $31.1K |
| 2026-08-13 | Polen Thomas E Jr | Chairman, CEO and President, Director | Sale | $768.1K |
| 2026-07-27 | Feld Michael | EVP, Chief Revenue Officer | Sale | 1.8K |
| 2026-06-26 | Feld Michael | EVP, Chief Revenue Officer | Sale | 1.5K |
| 2026-06-24 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sale | 60.2K |
| 2026-06-10 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sale | 66.6K |